CitroTech (CITR) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q/A for Q2 FY2026, filed Aug 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CITR SEC filings page.
CitroTech Inc. (CITR) reported $2.4M in revenue for fiscal year 2025, up 194.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue is scaling quickly, but the business still consumes cash and relies on financing to support expansion.
FY2025 revenue reached$2.4M while operating cash flow was-$5.9M , showing that reported growth is not yet converting into operating cash. With free cash flow at-$6.1M and financing cash flow at$11.7M , the reported funding pattern indicates that financing—not internally generated cash—covered the gap.
Gross economics improved: gross margin rose from
Liquidity became less constrained: the current ratio increased from 0.7x in FY2024 to 3.4x in FY2025. Liabilities grew
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of CitroTech Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
CitroTech Inc. held $6.3M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $5.9M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and CitroTech Inc. scores 37/100 among other emerging companies.
CitroTech Inc. had 19M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and CitroTech Inc. scores 92/100 among other emerging companies.
CitroTech Inc. spent $199K on research and development in fiscal year 2025, which was 1.1% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and CitroTech Inc. scores 9/100 among other emerging companies.
CitroTech Inc. reported revenue of $2.4M in fiscal year 2025, against $808K in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and CitroTech Inc. scores 87/100 among other emerging companies.
CitroTech Inc.'s operations used $5.9M of cash in fiscal year 2025, against $1.9M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and CitroTech Inc. scores 6/100 among other emerging companies.
CitroTech Inc.'s cash, cash equivalents and investments came to $6.3M at the end of fiscal year 2025, against $2.9M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and CitroTech Inc. scores 76/100 among other emerging companies.
CitroTech Inc. scores -2.87, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $113.2M against total assets of $14.2M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
CitroTech Inc. passes 5 of 9 financial strength tests. 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
CitroTech Inc. reported a net loss of $36.8M while operations used $5.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.
CitroTech Inc. reported an operating loss of $16.5M against $1.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
CitroTech Inc. generated $281K in revenue in Q2 2026. This represents a decrease of 59.2% from the same quarter a year earlier. Against the prior quarter it is down 18.6%.
CitroTech Inc.'s EBITDA was -$3.4M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
CitroTech Inc. reported a net loss of $3.9M in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
CitroTech Inc. earned -$0.18 per diluted share (EPS) in Q2 2026. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
CitroTech Inc. recorded an outflow of $1.8M in free cash flow in Q2 2026, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
CitroTech Inc. held $2.5M in cash against $0 in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
CitroTech Inc.'s gross margin was 3.2% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 42.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 31.4 percentage points.
CitroTech Inc.'s quarterly ROE was -43.3% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is up 500.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 28.2 percentage points.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
CitroTech Inc. invested $197K in research and development in Q2 2026. This represents an increase of 377.4% from the same quarter a year earlier. Against the prior quarter it is up 141.7%.
CitroTech Inc. reported no capital expenditure in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.
Not reported for Q2 2026.
CITR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q/A | Q1'2610-Q | Q4'25S-1/A | Q3'2510-Q | Q2'2510-Q/A | Q1'2510-Q | Q4'24S-1/A | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $281K-59.2% | $345K-64.4% | $436K+526.3% | $288K+169.3% | $688K+246.1% | $969K+123.9% | $70K-73.4% | $107K-38.7% |
| Cost of Revenue | $272K-26.9% | $226K-63.5% | $286K-11.7% | $576K+313.6% | $371K+263.4% | $617K+586.8% | $324K+333.0% | $139K+249.0% |
| Gross Profit | $9K-97.1% | $119K-66.1% | $150Kn/m | -$287Kn/m | $316K+227.8% | $352K+2.6% | -$255K-236.1% | -$32K-123.8% |
| R&D Expenses | $197K+377.4% | $82K+915.1% | N/A | N/A | $41K | $8K | N/A | N/A |
| SG&A Expenses | $218K-19.2% | $410K+101.8% | $771K | $349K+168.8% | $270K+67.4% | $203K-2.1% | N/A | $130K+48.5% |
| Operating Income | -$3.5Mn/m | -$4.4Mn/m | -$5.8Mn/m | -$4.2Mn/m | -$3.0Mn/m | -$3.5Mn/m | -$1.2Mn/m | -$561Kn/m |
| EBITDA | -$3.4Mn/m | -$4.3Mn/m | -$5.7Mn/m | -$4.1Mn/m | -$2.9Mn/m | -$3.4Mn/m | -$1.1Mn/m | -$498Kn/m |
| Interest Expense | $4K-99.4% | $165K-59.9% | $188K+15.2% | $360K+283.7% | $552Kn/m | $411K+46317.1% | $163K+8911.7% | $94K+5233.8% |
| Income Tax | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Net Income | -$3.9Mn/m | -$6.2Mn/m | -$6.1Mn/m | -$7.9Mn/m | -$11.9Mn/m | -$10.9Mn/m | -$1.8Mn/m | -$655Kn/m |
| EPS (Basic) | -$0.18 | -$0.33 | N/A | N/A | -$1.14 | -$1.37 | N/A | N/A |
| EPS (Diluted) | -$0.18 | -$0.33 | -$0.08 | -$0.59 | -$1.14 | -$1.37 | -$0.05-150.0% | -$0.11 |
| Diluted Shares (Avg) | 22M | 19M | N/A | 14M | 10M | 8M | N/A | 6M |
CITR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q/A | Q1'2610-Q | Q4'25S-1/A | Q3'2510-Q | Q2'2510-Q/A | Q1'2510-Q | Q4'24S-1/A | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.0M+15.5% | $12.2M+35.2% | $14.2M+158.9% | $12.3M+148.0% | $8.7M+62.3% | $9.1M+72.3% | $5.5M+3.3% | $4.9M-6.7% |
| Current Assets | $3.7M-2.6% | $5.6M+12.3% | $7.4M+358.5% | $7.3M+553.7% | $3.8M+163.5% | $5.0M+300.0% | $1.6M+32.8% | $1.1M+17.2% |
| Cash & Equivalents | $2.5M+8.3% | $4.3M+14.6% | $6.3M+708.7% | $6.2M+1904.3% | $2.3M+325.8% | $3.7M+907.9% | $775K+41.0% | $309K-45.4% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Inventory | $579K+41.3% | $696K+122.8% | $621K+91.2% | $467K+72.4% | $410K+113.4% | $312K+65.5% | $325K+41.0% | $271K+46.8% |
| Accounts Receivable | $165K-74.7% | $130K-82.5% | $209K-34.1% | $508K+18.2% | $654K+0.5% | $746K+9.5% | $317K-25.7% | $430K+135.8% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Total Liabilities | $1.0M-84.3% | $3.6M-28.3% | $2.9M+35.1% | $3.8M+77.7% | $6.5M+203.9% | $5.0M+232.8% | $2.2M+29.6% | $2.1M+17.9% |
| Current Liabilities | $420K-92.8% | $2.9M-42.5% | $2.2M+0.4% | $3.0M+40.7% | $5.8M+172.4% | $5.0M+239.4% | $2.2M+33.6% | $2.1M+22.7% |
| Non-Current Liabilities | $603K-13.1% | $703Kn/m | $751Kn/m | $781Kn/m | $694K+9446.5% | $0-100.0% | $0-100.0% | $0-100.0% |
| Long-Term Debt | $0 | $0 | $0n/m | $125K | N/A | N/A | $0 | N/A |
| Total Equity | $9.0M+311.4% | $8.7M+112.3% | $11.3M+239.7% | $8.5M+200.4% | $2.2M-31.9% | $4.1M+8.7% | $3.3M-8.8% | $2.8M-14.7% |
| Retained Earnings | -$123.3Mn/m | -$119.4Mn/m | -$113.2Mn/m | -$107.1Mn/m | -$99.2Mn/m | -$87.3Mn/m | -$76.4Mn/m | -$74.6Mn/m |
Not reported in any period shown, so not listed: Goodwill.
CITR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q/A | Q1'2610-Q | Q4'25S-1/A | Q3'2510-Q | Q2'2510-Q/A | Q1'2510-Q | Q4'24S-1/A | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.8Mn/m | -$2.1Mn/m | -$2.5Mn/m | -$1.5Mn/m | -$1.2Mn/m | -$714Kn/m | -$618Kn/m | -$551Kn/m |
| Depreciation & Amortization | $124K+60.6% | $126K+68.6% | $88K+17.7% | $90K+41.5% | $77K+22.9% | $75K+16.8% | $74K+19.7% | $64K+2.4% |
| Stock-Based Compensation | $1.9M-55.7% | $2.3M-74.5% | N/A | N/A | $4.4M | $8.9M+272.7% | N/A | N/A |
| Capital Expenditures | $0-100.0% | $11K-60.3% | N/A | $54Kn/m | $141Kn/m | $27Kn/m | $0-100.0% | $0-100.0% |
| Free Cash Flow | -$1.8Mn/m | -$2.1Mn/m | N/A | -$1.5Mn/m | -$1.4Mn/m | -$741Kn/m | -$618Kn/m | -$551Kn/m |
| Investing Cash Flow | $13Kn/m | -$11Kn/m | -$72Kn/m | -$54Kn/m | -$141Kn/m | -$27Kn/m | $0n/m | $0n/m |
| Financing Cash Flow | $3Kn/m | $88K-97.6% | $2.6M+142.4% | $5.4M+1615.3% | -$61K-110.1% | $3.7M+2146.1% | $1.1M+187.1% | $314K-64.3% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
CITR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q/A | Q1'2610-Q | Q4'25S-1/A | Q3'2510-Q | Q2'2510-Q/A | Q1'2510-Q | Q4'24S-1/A | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.2%-42.8pp | 34.6%-1.7pp | 34.3% | -99.7%-69.7pp | 46.0%-2.6pp | 36.3%-42.9pp | -365.6% | -30.0%-107.2pp |
| Operating Margin | -1244.9% | -1289.3% | -1325.7% | -1470.3% | -438.8% | -356.8% | -1722.2% | -524.4% |
| Net Margin | -1390.5% | -1800.6% | -1398.8% | -2751.2% | -1731.1% | -1124.8% | -2583.7% | -612.1% |
| Return on Equity | -43.3%+500.1pp | -71.5%+195.0pp | -54.2%+0.1pp | -93.2%-70.0pp | -543.4%-515.2pp | -266.5%-173.0pp | -54.3%-49.2pp | -23.1%+250.6pp |
| Return on Assets | -38.9%+98.1pp | -50.7%+69.7pp | -43.0%-10.2pp | -64.6%-51.4pp | -137.0%-120.1pp | -120.5%-53.5pp | -32.9%-29.4pp | -13.3%+158.2pp |
| Current Ratio | 8.77+8.1x | 1.97+1.0x | 3.42+2.7x | 2.44+1.9x | 0.650.0x | 1.01+0.2x | 0.750.0x | 0.530.0x |
| Debt-to-Equity | 0.00 | 0.00 | 0.000.0x | 0.01 | N/A | N/A | 0.00 | N/A |
| Liabilities-to-Equity | 0.11-2.9x | 0.41-0.8x | 0.26-0.4x | 0.44-0.3x | 2.97+2.3x | 1.21+0.8x | 0.65+0.2x | 0.75+0.2x |
| Asset Turnover | 0.03-0.1x | 0.03-0.1x | 0.030.0x | 0.020.0x | 0.080.0x | 0.110.0x | 0.010.0x | 0.020.0x |
| FCF Margin | -635.4% | -600.2% | N/A | -525.6% | -196.7% | -76.4%+2.9pp | -887.1% | -515.0% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| CitroTech Inc. CITR | FY2025 | $2.4M | -$36.8M | N/A | $56.1M | 51/100 |
| Northern Technologies International Corp. NTIC | FY2025 | $84.2M | $18K | 0.0% | $70.7M | 51/100 |
| Flexible Solutions International, Inc. FSI | FY2025 | $38.5M | $787K | 2.0% | $78.6M | 60/100 |
| 5E Advanced Materials, Inc. FEAM | FY2026 | N/A | -$42.9M | N/A | $94.8M | — |
| Ascent Industries Co. ACNT | FY2025 | $74.9M | $867K | 1.2% | $124.0M | 41/100 |
| Aemetis, Inc. (DE) AMTX | FY2025 | $197.6M | -$77.0M | -39.0% | $116.9M | 51/100 |
Where CitroTech Inc. Ranks
Frequently Asked Questions
CitroTech Inc. (CITR) reported $2.4M in total revenue for fiscal year 2025. This represents a 194.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
CitroTech Inc. (CITR) revenue grew by 194.6% year-over-year, from $808K to $2.4M in fiscal year 2025.
No, CitroTech Inc. (CITR) reported a net loss of $36.8M in fiscal year 2025.
CitroTech Inc. (CITR) had EBITDA of -$16.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, CitroTech Inc. (CITR) had $6.3M in cash and equivalents against $0 in long-term debt.
CitroTech Inc. (CITR) had a gross margin of 22.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
CitroTech Inc. (CITR) has a return on equity of -327.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
CitroTech Inc. (CITR) recorded an outflow of $6.1M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
CitroTech Inc. (CITR) recorded an outflow of $5.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
CitroTech Inc. (CITR) had $14.2M in total assets as of fiscal year 2025, including both current and long-term assets.
CitroTech Inc. (CITR) invested $194K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
CitroTech Inc. (CITR) invested $199K in research and development during fiscal year 2025.
CitroTech Inc. (CITR) had a current ratio of 3.42 as of fiscal year 2025, which is generally considered healthy.
CitroTech Inc. (CITR) had a debt-to-equity ratio of 0.00 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
CitroTech Inc. (CITR) had a liabilities-to-equity ratio of 0.26 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
CitroTech Inc. (CITR) had a return on assets of -259.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
CitroTech Inc. (CITR) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $56.1M as of Nov 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
CitroTech Inc. (CITR) trades at 41.6x sales, its market capitalization divided by $1.3M revenue, trailing 12 months to June 30, 2026. The market capitalization is $56.1M as of Nov 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
At the end of fiscal year 2025, CitroTech Inc. (CITR) held $6.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $5.9M over that year. Dividing the one by the other, the reported balance equals about 13 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
CitroTech Inc. (CITR) has an Altman Z-Score of -2.87, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
CitroTech Inc. (CITR) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
CitroTech Inc. (CITR) reported a net loss of $36.8M while operations used $5.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
CitroTech Inc. (CITR) reported an operating loss of $16.5M against $1.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
CitroTech Inc. (CITR) scores 51 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.